{"name":"Jina Pharmaceuticals Inc.","slug":"jina-pharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Conventional paclitaxel or Taxol","genericName":"Conventional paclitaxel or Taxol","slug":"conventional-paclitaxel-or-taxol","indication":"Metastatic carcinoma of the ovary","status":"phase_3"},{"name":"Paclitaxel Lipid Suspension","genericName":"Paclitaxel Lipid Suspension","slug":"paclitaxel-lipid-suspension","indication":"Adjuvant treatment of node-positive breast cancer","status":"phase_3"}]}],"pipeline":[{"name":"Conventional paclitaxel or Taxol","genericName":"Conventional paclitaxel or Taxol","slug":"conventional-paclitaxel-or-taxol","phase":"phase_3","mechanism":"Paclitaxel stabilizes microtubules by binding to β-tubulin, preventing their depolymerization and causing cell cycle arrest and apoptosis in cancer cells.","indications":["Metastatic carcinoma of the ovary","Breast cancer (metastatic and adjuvant)","Non-small cell lung cancer","Kaposi's sarcoma","Various solid tumors (phase 3 pipeline)"],"catalyst":""},{"name":"Paclitaxel Lipid Suspension","genericName":"Paclitaxel Lipid Suspension","slug":"paclitaxel-lipid-suspension","phase":"phase_3","mechanism":"Paclitaxel works by inhibiting cell division, thereby preventing cancer cells from multiplying.","indications":["Adjuvant treatment of node-positive breast cancer","Adjuvant treatment of ovarian cancer","Adjuvant treatment of non-small cell lung cancer","Treatment of AIDS-related Kaposi's sarcoma"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxQWTJTY29nUEgxWEZFT1JuVG9HR0VEQy03WlI3bTZUcnNmUzhkb3BiWEFSR3lvclZfTFctWi1mYWs0dWgxNWk1NC13VU1QOFZDd0ctNm83bDN5U0tfczVvcVZQUVFaYnF3eWJUTWtmS25QZkF1RF8tX2wzb25ud2J1TS0xREM?oc=5","date":"2022-02-07","type":"trial","source":"globaldata.com","summary":"Bipolar Disorder – Global Drug Forecast and Market Analysis to 2030 - globaldata.com","headline":"Bipolar Disorder – Global Drug Forecast and Market Analysis to 2030","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxOVHlGeHQ1dzJMb0xDZ2xVRTRsdkh2VjljSWZBbUpVbFpBQ3VhWG16ZHZlYU9Xa3BkLVgtb05ZZWhFUG5ZUE1VTlZuRkllZFlCVy1Gb0I0bTcwUktLOXdaU1lsN1FRYk41WVR4VzIyaFV5aWtBSGJiM2ZvbkxOZjFIVWdBdmgzZEpieERnazhvbDJGcGNXWGpEY2tOUzhRZkFzM0gybktPLTdBY2M3S0o0clpsNEVHSUswVmVTdg?oc=5","date":"2020-06-05","type":"trial","source":"Oncology Nurse Advisor","summary":"Nanosomal Docetaxel Lipid Suspension-Based Chemotherapy in Breast Cancer: Results from a Multicenter Retrospective Study - Oncology Nurse Advisor","headline":"Nanosomal Docetaxel Lipid Suspension-Based Chemotherapy in Breast Cancer: Results from a Multicenter Retrospective Study","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":2},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}